
Feasibility and safety of sorafenib treatment in hepatocellular carcinoma patients with spontaneous rupture
Author(s) -
Shunzhen Zheng,
Dejie Liu,
Ping Sun,
Yonglang Guo,
Xu Yang,
Wei Gong,
Jun Li
Publication year - 2014
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v20.i43.16275
Subject(s) - sorafenib , medicine , hepatocellular carcinoma , surgery , single center , retrospective cohort study , gastroenterology
To report the outcome of patients with ruptured hepatocellular carcinoma (HCC) treated at a single center during a 5-year period.